TEFLON DRY LUBE (NON-CHLORINATED)

Emergency Overview 

Change in color: Not available

Physical Form: liquid

Odor:  distinct odor 

Health Hazards:  respiratory tract irritation, skin irritation, aspiration hazard, central nervous system depression, difficulty breathing, nerve damage, kidney damage, birth defects, suspect cancer hazard (in animals) 

Physical Hazards:  Containers may rupture or explode if exposed to heat. 

Short Term:  irritation, nausea, vomiting, diarrhea, constipation, stomach pain, chest pain, difficulty breathing, irregular heartbeat, headache, drowsiness, fatigue, dizziness, disorientation, sleep disturbances, emotional disturbances, mood swings, tingling sensation, muscle cramps, loss of coordination, visual disturbances, suffocation, kidney damage, liver damage, paralysis, brain damage, convulsions, unconsciousness, coma 

Long Term:  same as effects reported in short term exposure, irritation, changes in blood pressure, nausea, vomiting, loss of appetite, weight loss, irregular heartbeat, headache, drowsiness, dizziness, disorientation, mood swings, joint pain, loss of coordination, eye damage, hormonal disorders, suffocation, blood disorders, nerve damage, reproductive effects, birth defects, convulsions, unconsciousness, coma 

Short Term:  irritation, blisters 

Long Term:  irritation 

Short Term:  irritation, blurred vision 

Long Term:  irritation 

Short Term:  ingestion of a gas is unlikely, same as effects reported in short term inhalation, headache, drowsiness, dizziness, loss of coordination, aspiration hazard 

Long Term:  ingestion of a gas is unlikely, same as effects reported in long term inhalation 

This product may be regulated, have exposure limits or other information identified as the following: Lead compounds, Lead compounds, organic, Aliphatic hydrocarbon gases (Alkane [C1-C4]).

If adverse effects occur, remove to uncontaminated area. Get medical attention. 

If frostbite or freezing occur, immediately flush with plenty of lukewarm water (105-115 F; 41-46 C). DO NOT USE HOT WATER. If warm water is not available, gently wrap affected parts in blankets. Get immediate medical attention. 

Flush eyes with plenty of water. 

If a large amount is swallowed, get medical attention. 

See Section 9 for Flammability Properties 

Severe fire hazard. Containers may rupture or explode if exposed to heat. 

carbon dioxide, regular dry chemical 

Move container from fire area if it can be done without risk. Cool containers with water spray until well after the fire is out. Avoid inhalation of material or combustion by-products. Stay upwind and keep out of low areas. 

Subject to California Safe Drinking Water and Toxic Enforcement Act of 1986 (Proposition 65). Keep out of water supplies and sewers. 

Avoid heat, flames, sparks and other sources of ignition. Do not touch spilled material. Stop leak if possible without personal risk. Small spills of the liquid component: Absorb with sand or other non-combustible material. Collect spilled material in appropriate container for disposal. Spills with a large number of canisters: Reduce vapors with water spray. Remove sources of ignition. Notify Local Emergency Planning Committee and State Emergency Response Commission for release greater than or equal to RQ (U.S. SARA Section 304). If release occurs in the U.S. and is reportable under CERCLA Section 103, notify the National Response Center at (800)424-8802 (USA) or (202)426-2675 (USA). 

Store and handle in accordance with all current regulations and standards. Subject to storage regulations: U.S. OSHA 29 CFR 1910.101. See original container for storage recommendations. Keep separated from incompatible substances. 

If an employee is exposed to lead for more than 8 hours in any work day, the permissible exposure limit, as a time weighted average (TWA) for that day, shall be reduced according to the following formula: Maximum permissible limit (in ug/m3) = 400 divided by hours worked in the day. 

Component Exposure Limits 

Biological limit value 

Provide local exhaust ventilation system. Ventilation equipment should be explosion-resistant if explosive concentrations of material are present. 

Eyes/Face For the gas: Eye protection not required, but recommended. For the liquid: Wear splash resistant safety goggles. Contact lenses should not be worn. Provide an emergency eye wash fountain and quick drench shower in the immediate work area. 

For the gas: Protective clothing is not required. For the liquid: Wear appropriate protective, cold insulating clothing. 

Wear insulated gloves. 

No respirator is required under normal conditions of use. Under conditions of frequent use or heavy exposure, respiratory protection may be needed. 

Stable at normal temperatures and pressure. 

Avoid heat, flames, sparks and other sources of ignition. Containers may rupture or explode if exposed to heat. 

oxidizing materials 

oxides of carbon, miscellaneous decomposition products 

Will not polymerize. 

Component Analysis - LD50/LC50 

Component Carcinogenicity

Renal tumors were produced in animals by lead acetate, lead subacetate, and lead phosphate given orally, subcutaneously, or intraperitoneally No evaluation could be made of the carcinogenicity of powdered lead. 

kidney disorders, blood system disorders, liver disorders, gastrointestinal disorders, respiratory disorders, nervous system disorders, skin disorders and allergies, respiratory disorders, heart or respiratory disorders, 

Stimulants such as epinephrine may induce ventricular fibrillation Stimulants such as epinephrine may induce ventricular fibrillation Alcohol may enhance the toxic effects Stimulants such as epinephrine may induce ventricular fibrillation Smoking may result in higher blood lead levels. 

May potentiate the effects of toxic agents, such as tri-o-cresyl phosphate. 

CYCLOHEXANE: Low concentrations may cause irritation of the respiratory tract Exposure to concentrations above 12,000 ppm may cause central nervous system depression with excitement, headache, dizziness, dullness, nausea, vomiting, narcosis, coma, and possibly death due to respiratory failure Lethal concentrations to animals caused convulsions and generalized vascular damage with severe degenerative changes in the heart, lungs, liver, kidneys, and brain ISOBUTANE: Vapors may be irritating to the mucous membranes Humans exposed to 250-1000 ppm for 1 minute to 8 hours did not exhibit any adverse effects Higher concentrations may cause central nervous system depression and asphyxiation Symptoms may include dizziness, difficulty in breathing, loss of consciousness, muscular incoordination, headache, weakness, emotional instability, nausea, vomiting, prostration, convulsions, coma, and death Animals exposed to near lethal levels exhibited central nervous system depression, rapid and shallow respiration, and apnea Cardiac sensitization has been reported in animals LEAD COMPOUNDS: Absorption of large amounts of lead may cause a metallic taste, thirst, a burning sensation in the mouth and throat, salivation, abdominal pain with severe colic, vomiting, diarrhea of black or bloody stools, constipation, fatigue, sleep disturbances, dullness, restlessness, irritability, memory loss, loss of concentration, delirium, oliguria often with hematuria and albuminuria, encephalopathy with visual failure, paresthesias, muscle pain and weakness, convulsions, and paralysis Death may result from cardiorespiratory arrest or shock Survivors of acute exposure may experience the onset of chronic intoxication Liver effects may include enlargement and tenderness, and jaundice The fatal dose of absorbed lead is approximately 0.5 grams Pathological findings include gastrointestinal inflammation and renal tubular degeneration LPG: Vapors may cause narcosis with headache, dullness, difficulty breathing, lightheadedness, drowsiness, unconsciousness and possibly death Concentrations for 10 minutes may cause dizziness Very high concentrations may cause asphyxiation with rapid respiration, dyspnea, reduced mental alertness and muscle coordination, nausea, vomiting, prostration, unconsciousness, convulsions, coma and death PROPANE: Brief exposure to 10,000 ppm caused no symptoms in human subjects; 100,000 ppm produced slight dizziness in a few minutes but was not noticeably irritating to the nose or respiratory tract High levels may produce disorientation, excitation, excessive salivation, headache and vomiting In primates, 100,000 ppm produced some myocardial effects and at 200,000 ppm aggravation of these parameters and respiratory depression Concentrations of 100,000 ppm in mice and 150,000 ppm in dogs appear to produce no arrhythmia but weak cardiac sensitization Concentrations of 75% may produce nausea, vomiting, prostration, unconsciousness, convulsions, deep coma and death SIMPLE ASPHYXIANTS: The symptoms of asphyxia depend on the rapidity with which the oxygen deficiency develops and how long it continues In sudden acute asphyxia, unconsciousness may be immediate With slow development there may be rapid respiration and pulse, air hunger, dizziness, reduced awareness, tightness in the head, tingling sensations, incoordination, faulty judgement, emotional instability, and rapid fatigue As the asphyxia progresses, nausea, vomiting, collapse, unconsciousness, convulsions, deep coma and death are possible.

ISOBUTANE: No adverse effects have been reported from human exposure to 500 ppm for 1-8 hours/day for 10 days LEAD COMPOUNDS: Prolonged or repeated exposure to low levels of lead may result in an accumulation in body tissues and exert adverse effects on the blood, nervous systems, heart, endocrine and immune systems, kidneys, and reproduction Early stages of lead poisoning, "plumbism", may be evidenced by anorexia, weight loss, constipation, apathy or irritability, occasional vomiting, fatigue, headache, weakness, metallic taste in the mouth, gingival lead line in persons with poor dental hygiene, and anemia Loss of recently developed motor skills is generally observed only in children More advanced stages of poisoning may be characterized by intermittent vomiting, irritability and nervousness, myalgia of the arms, legs, joints and abdomen, paralysis of the extensor muscles of the arms and legs with wrist and/or foot drop Severe "plumbism" may result in persistent vomiting, ataxia, periods of stupor or lethargy, encephalopathy with visual disturbances which may progress to optic neuritis and atrophy, hypertension, papilledema, cranial nerve paralysis, delirium, convulsions, and coma Neurologic sequelae may include mental retardation, seizures, cerebral palsy, and dystonia musculorum deformans Irreversible kidney damage has been associated with industrial exposure Reproductive effects have been exhibited in both males and females Paternal effects may include decreased sex drive, impotence, sterility and adverse effects on the sperm which may increase the risk of birth defects Maternal effects may include miscarriage and stillbirths in exposed women or women whose husbands were exposed, abortion, sterility or decreased fertility, and abnormal menstrual cycles Lead crosses the placenta and may affect the fetus causing birth defects, mental retardation, behavioral disorders, and death during the first year of childhood Animal studies indicate that reproductive effects may be additive if both parents are exposed to lead LPG: No data available PROPANE: Repeated contact may result in symptoms as described in acute exposure CYCLOHEXANE: Repeated or prolonged exposure to concentrations above 300 ppm may produce mild irritation of the upper respiratory tract Repeated exposures caused microscopic changes in the liver and kidneys, lethargy, light narcosis, diarrhea, and some deaths in animals Developmental toxicity studies in rats at 7000 ppm produced significantly decreased maternal body weight and food consumption and diminished response or no response to sound stimulus In the same studies, there was no evidence of developmental toxicity in any test concentrations (500, 2000 or 7000 ppm) In another study, no evidence of maternal or developmental toxicity was found in rabbits (500, 2000, or 7000 ppm) SIMPLE ASPHYXIANTS: No data available.

LEAD SALICYLATE: See information on lead compounds N-BUTANE: A 1% concentration for 10 minutes may cause drowsiness Higher concentrations may cause respiratory tract irritation, headache, dullness, shortness of breath, muscular weakness and paralysis, unconsciousness, and death Butane is a weak cardiac sensitizer in the dog Unless an odorant is added, the lack of warning properties may make overexposure more likely See information on LPG and simple asphyxiants.

LEAD COMPOUNDS: Contact with lead powders or dust may be irritating PROPANE: No adverse effects have been reported from the gas Due to rapid evaporation, the liquid may cause frostbite with redness, tingling and pain or numbness In more severe cases, the skin may become hard and white and develop blisters N-BUTANE: No adverse effects have been reported from the gas Due to rapid evaporation, the liquid may cause frostbite with redness, tingling and pain or numbness In more severe cases, the skin may become hard and white and develop blisters ISOBUTANE: No adverse effects have been reported from the gas Due to rapid evaporation, the liquid may cause frostbite with redness, tingling and pain or numbness In more severe cases, the skin may become hard and white and develop blisters CYCLOHEXANE: May cause irritation with redness and dryness Massive applications to rabbit skin have produced microscopic changes in the liver and kidneys.

N-BUTANE: No effects have been reported ISOBUTANE: No data available CYCLOHEXANE: Repeated or prolonged contact with the liquid may cause irritation, defatting of the skin, and a dry, scaly, fissured dermatitis PROPANE: No data available LEAD COMPOUNDS: Prolonged or repeated exposure to the powder or dust may result in dermatitis.

LEAD SALICYLATE See information on lead compounds.

CYCLOHEXANE: Contact with liquid or high vapor concentrations may cause irritation with tearing and redness, and a mild conjunctivitis ISOBUTANE: No adverse effects have been reported from the gas Due to rapid evaporation, the liquid may cause frostbite with redness, pain and blurred vision LEAD COMPOUNDS: Lead dust or powders may be irritating Metallic lead particles may cause an inflammatory foreign body reaction Injury is generally thought to be mechanical and not toxic N-BUTANE: No adverse effects have been reported from the gas Due to rapid evaporation, the liquid may cause frostbite with redness, pain and blurred vision PROPANE: Vapor concentrations of 100,000 ppm were not noticeably irritating to the eyes Due to rapid evaporation, the liquid may cause frostbite with redness, pain and blurred vision.

PROPANE: No data available N-BUTANE: No data available LEAD COMPOUNDS: Prolonged exposure may cause conjunctivitis ISOBUTANE: No data available CYCLOHEXANE: Repeated or prolonged exposure to irritants may cause conjunctivitis.

LEAD SALICYLATE See information on lead compounds.

CYCLOHEXANE: Lung damage may occur if aspirated into the lungs and may be fatal Symptoms may include coughing, difficulty breathing, cyanosis, and pulmonary edema May cause symptoms of central nervous system depression as detailed in acute inhalation ISOBUTANE: Ingestion of a gas is unlikely If the liquid is swallowed, frostbite damage of the lips, mouth and mucous membranes may occur PROPANE: Ingestion of a gas is unlikely If the liquid is swallowed, frostbite damage of the lips, mouth and mucous membranes may occur N-BUTANE: Ingestion of a gas is unlikely If liquid is swallowed, frostbite damage to the lips, mouth and mucous membranes may occur LEAD COMPOUNDS: Absorption of large amounts of lead from the intestinal tract may cause effects as detailed in acute inhalation The fatal dose of absorbed lead is approximately 0.5 grams.

PROPANE: Ingestion of a gas is unlikely N-BUTANE: Ingestion of a gas is unlikely LEAD COMPOUNDS: Prolonged or repeated exposure to low levels of lead may result in an accumulation in body tissues and adverse effects on the kidneys, heart and blood and on the nervous, reproductive, endocrine and immune systems as detailed in chronic inhalation ISOBUTANE: Ingestion of a gas is unlikely CYCLOHEXANE: No data available.

LEAD SALICYLATE See information on lead compounds.

Component Analysis - Aquatic Toxicity 

Bioconcentration Factor 

Dispose in accordance with all applicable regulations. Subject to disposal regulations: U.S. EPA 40 CFR 262. Hazardous Waste Number(s): D001. 

Component Waste Numbers 

ADR Tunnel Code Restrictions 

Component Marine Pollutants (IMDG) 

SARA Section 311/312 (40 CFR 370 Subparts B and C) 

The following statement(s) are provided under the California Safe Drinking Water and Toxic Enforcement Act of 1986 (Proposition 65): 

Canadian WHMIS Ingredient Disclosure List (IDL) 

Germany Water Classification 

REACH List of Substances Subject to Restriction (Annex XVII) - Reg. (EU) No. 1907/2006 

REACH List of Substances on Community Rolling Action Plan - Reg. (EU) No. 1907/2006 

The listed component(s) of this material have been checked for country-specific published classifications according to the Globally Harmonized System of Classification and Labeling (GHS). The results of the queries are displayed below. Please see the individual country listings, as additional interpretations or reference information may be available. For a reference list of H- or P-statements, please visit ChemADVISOR’s website at http://www.chemadvisor.com/product-resources/26-pure-substance-and-mixture-databases/247-ghs-hazard-and-physical-statements 

Australia GHS Classifications 

Australia GHS Labeling Information 

European Union GHS Classifications 

European Union GHS Labeling Information 

Indonesia GHS Classifications 

Japan GHS Classifications 

Japan GHS Labeling Information 

Korea GHS Classifications 

Korea GHS Labeling Information 

New Zealand GHS Classifications 

New Zealand GHS Labeling Information 

South Africa GHS Classifications 

Taiwan GHS Classifications 

Taiwan GHS Labeling Information 

No classification assigned. 

ACGIH - American Conference of Governmental Industrial Hygienists; ADR - European Road Transport; AU - Australia; BOD - Biochemical Oxygen Demand; C - Celsius; CA - Canada; CAS - Chemical Abstracts Service; CERCLA - Comprehensive Environmental Response, Compensation, and Liability Act; CN - China; CPR - Controlled Products Regulations; DFG - Deutsche Forschungsgemeinschaft; DOT - Department of Transportation; DSL - Domestic Substances List; EEC - European Economic Community; EINECS - European Inventory of Existing Commercial Chemical Substances; EPA - Environmental Protection Agency; EU - European Union; F - Fahrenheit; IARC - International Agency for Research on Cancer; IATA - International Air Transport Association; ICAO - International Civil Aviation Organization; IDL - Ingredient Disclosure List; IDLH - Immediately Dangerous to Life and Health; IMDG - International Maritime Dangerous Goods; JP - Japan; Kow - Octanol/water partition coefficient; KR - Korea; LEL - Lower Explosive Limit; LOLI - List Of LIsts™ - ChemADVISOR’s Regulatory Database; MAK - Maximum Concentration Value in the Workplace; MEL - Maximum Exposure Limits; NFPA - National Fire Protection Agency; NIOSH - National Institute for Occupational Safety and Health; NJTSR - New Jersey Trade Secret Registry; NTP - National Toxicology Program; NZ - New Zealand; OSHA - Occupational Safety and Health Administration; PH - Philippines; RCRA - Resource Conservation and Recovery Act; RID - European Rail Transport; RTECS - Registry of Toxic Effects of Chemical Substances®; SARA - Superfund Amendments and Reauthorization Act; STEL - Short-term Exposure Limit; TDG - Transportation of Dangerous Goods; TSCA - Toxic Substances Control Act; TWA - Time Weighted Average; UEL - Upper Explosive Limit; US - United States 

Reasonable care has been taken in the preparation of this information; however, the manufacturer makes no warranty whatsoever including the warranty of merchantability, expressed or implied, with respect to this information. The manufacturer makes no representations and assumes no liability for any direct, incidental, consequential, or other such damages resulting from its use or misuse. 

Supplier gives no warranty whatsoever, including the warranties of merchantability or of fitness for a particular purpose. Any product purchased is sold on the assumption the purchaser shall determine the quality and suitability of the product. Supplier expressly disclaims any and all liability for incidental, consequential or any other damages arising out of the use or misuse of this product. No information provided shall be deemed to be a recommendation to use any product in conflict with any existing patent rights. THIS SDS IS TO BE UTILIZED SOLELY AS A REFERENCE DOCUMENT AND IT IS NOT TO BE USED TO SATISFY THE DISTRIBUTION REQUIREMENTS OF OSHA'S HAZARD COMMUNICATION STANDARD (HCS) NOR CANADA'S CONTROLLED PRODUCT REGULATION (CPR). Read the Safety Data Sheet before handling product. Use of any information contained herein is provided at the reader's own risk and thus independent judgment by trained professionals must be utilized at all times. 

Copyright 1984-2016 ChemADVISOR, Inc "RTECS®" is a United States trademark owned and licensed under authority of the U.S. Government, by and through Accelrys/Biovia. Portions ©Copyright 2016, U.S. Government. All rights reserved